Last reviewed · How we verify

NCT06729528

Diagnostic Value of Whole-Body Computed Tomography (WBCT) Scores in Pediatric Trauma Patients

Completed Last updated 7 January 2026
What this trial tests

trial testing The PePCI and ManTIS scores in Whole Body Computed Tomography Imaging in 684 participants. Completed in 30 October 2025.

Timeline
13 November 2024
Primary endpoint
30 October 2025
30 October 2025

Quick facts

Lead sponsorMarmara University Pendik Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment684
Start date13 November 2024
Primary completion30 October 2025
Estimated completion30 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University Pendik Training and Research Hospital

Who can join

Under 18, any sex, with Whole Body Computed Tomography Imaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pediatric trauma assessment is challenging due to difficulties in obtaining information, which increases the need for unnecessary imaging. Trauma-related injuries remain a significant cause of death in children. Although whole-body computed tomography (CT) is frequently used due to a lower threshold for imaging, issues such as high radiation exposure arise. To reduce unnecessary radiation exposure in pediatric trauma patients, scoring systems such as PePCI (Pediatric Polytrauma CT Indication Score) and ManTIS (Manchester Trauma Imaging Score) have been developed. These studies have demonstrated their effectiveness in predicting the need for CT scans and preventing unnecessary examinations. However, both studies are retrospective analyses limited to a single region. Therefore, a prospective study is planned in Türkiye to evaluate the reliability and applicability of these scoring systems and their real-world benefits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Marmara University Pendik Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06729528.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing